BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27977579)

  • 1. The association of serum magnesium and mortality outcomes in heart failure patients: A systematic review and meta-analysis.
    Angkananard T; Anothaisintawee T; Eursiriwan S; Gorelik O; McEvoy M; Attia J; Thakkinstian A
    Medicine (Baltimore); 2016 Dec; 95(50):e5406. PubMed ID: 27977579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
    McCullough PA; Barnard D; Clare R; Ellis SJ; Fleg JL; Fonarow GC; Franklin BA; Kilpatrick RD; Kitzman DW; O'Connor CM; Piña IL; Thadani U; Thohan V; Whellan DJ;
    Clin Cardiol; 2013 Oct; 36(10):611-20. PubMed ID: 23929781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermagnesemia predicts mortality in elderly with congestive heart disease: relationship with laxative and antacid use.
    Corbi G; Acanfora D; Iannuzzi GL; Longobardi G; Cacciatore F; Furgi G; Filippelli A; Rengo G; Leosco D; Ferrara N
    Rejuvenation Res; 2008 Feb; 11(1):129-38. PubMed ID: 18279030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial).
    Vaduganathan M; Greene SJ; Ambrosy AP; Mentz RJ; Fonarow GC; Zannad F; Maggioni AP; Konstam MA; Subacius HP; Nodari S; Butler J; Gheorghiade M;
    Am J Cardiol; 2013 Dec; 112(11):1763-9. PubMed ID: 24095030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of magnesium alterations in patients with a myocardial infarction and left ventricular dysfunction: insights from the EPHESUS trial.
    Martens P; Ferreira JP; Vincent J; Abreu P; Busselen M; Mullens W; Tang WHW; Böhm M; Pitt B; Zannad F; Rossignol P
    Eur Heart J Acute Cardiovasc Care; 2022 Feb; 11(2):148-159. PubMed ID: 35021200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
    Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
    J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Dapagliflozin on Cause-Specific Mortality in Patients With Heart Failure Across the Spectrum of Ejection Fraction: A Participant-Level Pooled Analysis of DAPA-HF and DELIVER.
    Desai AS; Jhund PS; Claggett BL; Vaduganathan M; Miao ZM; Kondo T; Barkoudah E; Brahimi A; Connolly E; Finn P; Lang NN; Mc Causland FR; McGrath M; Petrie MC; McMurray JJV; Solomon SD
    JAMA Cardiol; 2022 Dec; 7(12):1227-1234. PubMed ID: 36189985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Ibrahim NE; Gaggin HK; Rabideau DJ; Gandhi PU; Mallick A; Januzzi JL
    J Card Fail; 2017 Feb; 23(2):121-130. PubMed ID: 27469482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exercise-based rehabilitation for heart failure.
    Taylor RS; Sagar VA; Davies EJ; Briscoe S; Coats AJ; Dalal H; Lough F; Rees K; Singh S
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD003331. PubMed ID: 24771460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between galectin-3 levels and mineralocorticoid receptor antagonist use in heart failure: analysis from HF-ACTION.
    Fiuzat M; Schulte PJ; Felker M; Ahmad T; Neely M; Adams KF; Donahue MP; Kraus WE; Piña IL; Whellan DJ; O'Connor CM
    J Card Fail; 2014 Jan; 20(1):38-44. PubMed ID: 24304938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exercise-based cardiac rehabilitation for adults with heart failure.
    Long L; Mordi IR; Bridges C; Sagar VA; Davies EJ; Coats AJ; Dalal H; Rees K; Singh SJ; Taylor RS
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD003331. PubMed ID: 30695817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between abnormal serum magnesium levels and prognosis of elderly patients with community-acquired pneumonia.
    Wang SQ; Lu DX; Zhang JD; Wang ZW; Li XW; Ma CM
    Magnes Res; 2021 Nov; 34(4):159-165. PubMed ID: 35212628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting death due to progressive heart failure in patients with mild-to-moderate chronic heart failure.
    Kearney MT; Fox KA; Lee AJ; Prescott RJ; Shah AM; Batin PD; Baig W; Lindsay S; Callahan TS; Shell WE; Eckberg DL; Zaman AG; Williams S; Neilson JM; Nolan J
    J Am Coll Cardiol; 2002 Nov; 40(10):1801-8. PubMed ID: 12446064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE Study.
    Eichhorn EJ; Tandon PK; DiBianco R; Timmis GC; Fenster PE; Shannon J; Packer M
    J Am Coll Cardiol; 1993 Mar; 21(3):634-40. PubMed ID: 8436744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline fragmented QRS is associated with increased all-cause mortality in heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    Kanitsoraphan C; Rattanawong P; Mekraksakit P; Chongsathidkiet P; Riangwiwat T; Kanjanahattakij N; Vutthikraivit W; Klomjit S; Thavaraputta S
    Ann Noninvasive Electrocardiol; 2019 Mar; 24(2):e12597. PubMed ID: 30329201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnesium Disorders and Prognosis in Heart Failure: A Systematic Review.
    Voultsos P; Bazmpani MA; Papanastasiou CA; Papadopoulos CE; Efthimiadis G; Karvounis H; Kalogeropoulos AP; Karamitsos TD
    Cardiol Rev; 2022 Nov-Dec 01; 30(6):281-285. PubMed ID: 34001688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis(†): Meta-Analysis Global Group in Chronic heart failure (MAGGIC).
    Rusinaru D; Tribouilloy C; Berry C; Richards AM; Whalley GA; Earle N; Poppe KK; Guazzi M; Macin SM; Komajda M; Doughty RN;
    Eur J Heart Fail; 2012 Oct; 14(10):1139-46. PubMed ID: 22782968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis.
    Aimo A; Januzzi JL; Vergaro G; Ripoli A; Latini R; Masson S; Magnoli M; Anand IS; Cohn JN; Tavazzi L; Tognoni G; Gravning J; Ueland T; Nymo SH; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Tentzeris I; Tang WHW; Grodin J; Passino C; Emdin M
    Circulation; 2018 Jan; 137(3):286-297. PubMed ID: 29335288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.